| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
SPECIAL ARTICLE 2019 March 18
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
Purpose This study presents the 2016 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality. Materials and Methods Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database and follo...
SPECIAL ARTICLE 2019 March 18
Prediction of Cancer Incidence and Mortality in Korea, 2019
Purpose This study aimed to report on cancer incidence and mortality for the year 2019 to estimate Korea’s current cancer burden. Materials and Methods Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database, and cancer mortali...
ORIGINAL ARTICLE 2018 June 1
Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
Purpose Control of metastatic spread of colorectal cancer (CRC) remains as a major therapeutic challenge. [V4 Q5 ]dDAVP is a vasopressin peptide analog with previously reported anticancer activity against carcinoma tumors. By acting as a selective agonist of arginine vasopressi...
ORIGINAL ARTICLE 2018 June 6
Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells
Purpose Pim kinases are highly conserved serine/threonine kinases, and different expression patterns of each isoform (Pim-1, Pim-2, and Pim-3) have been observed in various types of human cancers, including gastric cancer. AZD1208 is a potent and selective inhibitor that affect...
Current Issue
Volume 51(2); Apr 2019
Volume 51(1); January 2019
Volume 50(4); October 2018
RSS feed
  • Most-cited are based on citations from 2017 ~ 2019.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2017;49(2):292-305.   Published online March 9, 2017    DOI: https://doi.org/10.4143/crt.2017.118
                                     Cited By 190
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.143
                                     Cited By 66
    Prediction of Cancer Incidence and Mortality in Korea, 2017
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee
    Cancer Res Treat. 2017;49(2):306-312.   Published online March 17, 2017    DOI: https://doi.org/10.4143/crt.2017.130
                                     Cited By 38
    Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
    Cancer Res Treat. 2017;49(1):246-254.   Published online July 7, 2016    DOI: https://doi.org/10.4143/crt.2016.066
                                     Cited By 26
    An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
    In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
    Cancer Res Treat. 2017;49(3):569-577.   Published online September 12, 2016    DOI: https://doi.org/10.4143/crt.2016.289
                                     Cited By 15
    Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012
    Mina Suh, Seolhee Song, Ha Na Cho, Boyoung Park, Jae Kwan Jun, Eunji Choi, Yeol Kim, Kui Son Choi
    Cancer Res Treat. 2017;49(3):798-806.   Published online November 11, 2016    DOI: https://doi.org/10.4143/crt.2016.186
                                  Supplementary         Cited By 15
    Lung Cancer Epidemiology in Korea
    Aesun Shin, Chang-Mo Oh, Byung-Woo Kim, Hyeongtaek Woo, Young-Joo Won, Jin-Soo Lee
    Cancer Res Treat. 2017;49(3):616-626.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.178
                                  Supplementary         Cited By 14
    Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
    In Hye Song, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, In Ah Park, Young-Ae Kim, Suk Young Park, Jin Roh, Gyungyub Gong, Hee Jin Lee
    Cancer Res Treat. 2017;49(2):399-407.   Published online July 27, 2016    DOI: https://doi.org/10.4143/crt.2016.215
                                  Supplementary         Cited By 13
    Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
    Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
    Cancer Res Treat. 2017;49(4):851-868.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.176
                                  Supplementary         Cited By 13
    Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
    Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller, Daniel A. Vallera
    Cancer Res Treat. 2017;49(4):1140-1152.   Published online February 20, 2017    DOI: https://doi.org/10.4143/crt.2016.491
                                     Cited By 13
    The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
    Jaeyun Jung, Hyang Sook Seol, Suhwan Chang
    Cancer Res Treat. 2018;50(1):1-10.   Published online September 13, 2017    DOI: https://doi.org/10.4143/crt.2017.307
                                     Cited By 13
    Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Kyung Su Kim, Jeanny Kwon, Kyubo Kim, Eui Kyu Chie
    Cancer Res Treat. 2017;49(3):824-833.   Published online August 26, 2016    DOI: https://doi.org/10.4143/crt.2016.336
                                     Cited By 12
    Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea
    Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
    Cancer Res Treat. 2017;49(3):607-615.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.139
                                  Supplementary         Cited By 11
    Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
    Mathias Lutz, Arik B. Schulze, Elisabeth Rebber, Stefanie Wiebe, Tarek Zoubi, Oliver M. Grauer, Torsten Keßler, Andrea Kerkhoff, Georg Lenz, Wolfgang E. Berdel
    Cancer Res Treat. 2017;49(2):548-552.   Published online July 12, 2016    DOI: https://doi.org/10.4143/crt.2016.110
                                     Cited By 10
    Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
    Boyun Kim, Hee Seung Kim, Soochi Kim, Guy Haegeman, Benjamin K. Tsang, Danny N. Dhanasekaran, Yong Sang Song
    Cancer Res Treat. 2017;49(2):338-349.   Published online July 18, 2016    DOI: https://doi.org/10.4143/crt.2016.175
                                     Cited By 10
    Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
    Ji Soo Park, Eun Ji Nam, Hyung Seok Park, Jung Woo Han, Jung-Yun Lee, Jieun Kim, Tae Il Kim, Seung-Tae Lee
    Cancer Res Treat. 2017;49(4):1012-1021.   Published online January 17, 2017    DOI: https://doi.org/10.4143/crt.2016.433
                                  Supplementary         Cited By 10
    Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
    Tonglei Liu, Shuang Liu, Yu Xu, Ruo Shu, Feng Wang, Cheng Chen, Yujian Zeng, Huayou Luo
    Cancer Res Treat. 2018;50(4):1396-1417.   Published online January 24, 2018    DOI: https://doi.org/10.4143/crt.2017.537
                                     Cited By 10
    Prediction of Cancer Incidence and Mortality in Korea, 2018
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2018;50(2):317-323.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.142
                                     Cited By 10
    Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
    Minkyu Jung, Jeeyun Lee, Tae Min Kim, Dae Ho Lee, Jin Hyung Kang, Sung Young Oh, Soo Jung Lee, Sang Joon Shin
    Cancer Res Treat. 2017;49(1):44-53.   Published online April 27, 2016    DOI: https://doi.org/10.4143/crt.2016.024
                                     Cited By 9
    Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
    Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam
    Cancer Res Treat. 2017;49(2):408-415.   Published online July 27, 2016    DOI: https://doi.org/10.4143/crt.2016.135
                                     Cited By 9
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Cancer Research and Treatment 2017; 49(4): 915-926.
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community